# AbbVie Inc. (ABBV) FY2025 Annual Balance Sheet

- Company: AbbVie Inc. (ABBV)
- Period: As of 2025-12-31
- Filing: FY2025 10-K, filed 2026-02-20, accession number 0001551152-26-000008
- Page: https://plicit.ai/financials/abbv/fy2025-annual-balance-sheet
- Chart image: https://plicit.ai/charts/abbv-fy2025-annual-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2025-12-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 133,960,000,000 US dollars
- **Current assets**: 29,062,000,000 US dollars
- **Non-current assets**: 104,898,000,000 US dollars
- **Liabilities (calculated)**: 137,188,000,000 US dollars
- **Current liabilities**: 43,289,000,000 US dollars
- **Non-current liabilities**: 93,899,000,000 US dollars
- **Equity**: negative 3,228,000,000 US dollars
- **Noncontrolling interest**: 42,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 12,589,000,000 US dollars
- **Prepaid expenses and other**: 6,265,000,000 US dollars
- **Cash and equivalents**: 5,229,000,000 US dollars
- **Inventories**: 4,951,000,000 US dollars
- **Short-term investments**: 28,000,000 US dollars
- **Intangible assets, net**: 52,641,000,000 US dollars
- **Goodwill**: 35,640,000,000 US dollars
- **Other assets**: 10,721,000,000 US dollars
- **Property and equipment, net**: 5,628,000,000 US dollars
- **Investments**: 268,000,000 US dollars
- **Accounts payable and accrued liabilities**: 34,734,000,000 US dollars
- **Current portion of long-term debt and finance lease obligations**: 6,056,000,000 US dollars
- **Short-term borrowings**: 2,499,000,000 US dollars
- **Long-term debt and finance lease obligations**: 58,941,000,000 US dollars
- **Other long-term liabilities**: 32,569,000,000 US dollars
- **Deferred income taxes**: 2,389,000,000 US dollars
- **Additional paid-in capital**: 22,495,000,000 US dollars
- **Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,838,678,628 shares issued as of December 31, 2025 and 1,831,594,494 as of December 31, 2024**: 18,000,000 US dollars
- **Noncontrolling interest**: 42,000,000 US dollars
- **Accumulated deficit**: negative 15,493,000,000 US dollars
- **Common stock held in treasury, at cost, 70,802,593 shares as of December 31, 2025 and 66,337,508 as of December 31, 2024**: negative 9,146,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 1,144,000,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.